Mirum Pharmaceuticals, Inc. (MIRM)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 01:25PM EDT. Market open.
| Previous close | 39.35 |
| Open | 39.46 |
| Bid | 38.79 x 100 |
| Ask | 39.14 x 100 |
| Day's range | 38.60 - 39.62 |
| 52-week range | 23.14 - 45.23 |
| Volume | |
| Avg. volume | 646,100 |
| Market cap | 1.853B |
| Beta (5Y monthly) | 1.14 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.31 |
| Earnings date | 31 Oct 2024 - 04 Nov 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 61.30 |
Business WireMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FOSTER CITY, Calif., September 11, 2024--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Investor's Business DailyFour Biotech Stocks Rally Toward Buy Points As Funds Load Up
Biotech stocks have been rallying as funds load up. Five stocks have been outperforming the vast majority in the IBD database.
ZacksMirum Pharmaceuticals (MIRM) Up 4.5% Since Last Earnings Report: Can It Continue?
Mirum Pharmaceuticals (MIRM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
© 2024 Yahoo. All rights reserved.